Brand Intelligence Graph
Company Overview
About NEOK Bio
NEOK Bio is targeting neuroinflammation — the chronic activation of brain immune cells (microglia and astrocytes) — as a primary driver of neurodegeneration in Alzheimer's disease, ALS, and Parkinson's disease. The company's small molecule drug candidates modulate the NLRP3 inflammasome and related innate immune pathways in the brain, aiming to reduce the toxic inflammatory environment that kills neurons over time.
Business Model & Competitive Advantage
Founded in 2022 and emerging from stealth in 2025, NEOK Bio's scientific foundation draws from decade-long academic research linking neuroinflammation biomarkers to disease progression rates. The $80M funding will advance lead candidates into IND-enabling studies targeting a 2026 clinical trial initiation for its ALS program.
Competitive Landscape 2025–2026
Neuroinflammation as a therapeutic target has gained significant traction following the partial success of anti-amyloid antibodies (Leqembi, Kisunla) in Alzheimer's — which work partly by reducing inflammatory burden — and the identification of microglial genetic variants (TREM2, CD33) as major Alzheimer's risk factors. NEOK Bio's approach complements amyloid-targeting strategies by addressing the inflammatory component of neurodegeneration.
Key Differentiators
Emerging Innovator
NEOK Bio is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Muna Therapeutics
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Compare NEOK Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from NEOK Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim NEOK Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention NEOK Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →